Long-term outcomes of heart rhythm disorder treatment in Hamburg patients
Follows adults treated for heart rhythm disorders to see which factors predict recurrence.
Plain-language title generated from the registry record
Registry title: Clinical Cohort Study - TRUST
Key facts
- Where
- Hamburg, GermanySee the site
Where in Germany
- University Hospital Hamburg-Eppendorf, University Heart and Vascular CenterHamburg, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitätsklinikum Hamburg-Eppendorf
- Trial code
- NCT05521451
- Record updated
- 30 March 2025
- Original description
The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.Read full original descriptionShow less
Longterm Outcome and Predictors for Recurrence After Medical and Interventional Treatment of Arrhythmias At the University Heart Center Hamburg
The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.
Inclusion: Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia; Age ≥ 18 years; Written informed consent; Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation.
Exclusion: Insufficient knowledge of the German language to understand study documents and interview without translation; Physical or psychological incapability to cooperate in the investigation.